Both in Pharmaceuticals
Keros Therapeutics vs Niagen Bioscience
Over the past year KROS returned −30.4% and NAGE returned −63.7%; their daily moves had a correlation of 0.26.
KROS −30.4% NAGE −63.7%Growth of $1, one year, split-adjusted
| Metric | KROS | NAGE |
|---|---|---|
| Price | $10.83 | $2.52 |
| Market cap | $214.7M | $199.4M |
| Today | 0.00% | +6.78% |
| 1 month | −1.6% | −6.3% |
| 6 months | −8.1% | −49.3% |
| Year to date | −46.8% | −60.4% |
| 1 year | −28.8% | −65.1% |
| Revenue growth (YoY) | −100.0% | −4.3% |
| Gross margin | — | 64.8% |
| Net margin | — | 3.2% |
| P/E (TTM) | — | 12.5× |
| Price / sales | 14.3× | 1.5× |
| Net cash | $257.6M | $66.7M |
| Dividend yield | — | — |
| Volatility (60d) | 43.2% | 39.7% |
| Short % of float | 6.2% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).